SEARCH:   Advanced

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Wang, J. C.Y. Articles by Dick, J. E. Search for Related Content PubMed PubMed Citation Articles by Wang, J. C.Y. Articles by Dick, J. E. Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, Vol. 89 No. 11 (June 1), 1997: pp. 3919-3924 RAPID COMMUNICATION Primitive Human Hematopoietic Cells Are Enriched in Cord Blood Compared With Adult Bone Marrow or Mobilized Peripheral Blood as Measured by the Quantitative In Vivo SCID-Repopulating Cell Assay By Jean C.Y. Wang, Monica Doedens, and John E. Dick From the Department of Genetics, Research Institute, Hospital for Sick Children; and the Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada.     ABSTRACT Abstract Introduction Methods Results Discussion References We have previously reported the development of in vivo functional assays for primitive human hematopoietic cells based on their ability to repopulate the bone marrow (BM) of severe combined immunodeficient (SCID) and nonobese diabetic/SCID (NOD/SCID) mice following intravenous transplantation. Accumulated data from gene marking and cell purification experiments indicate that the engrafting cells (defined as SCID-repopulating cells or SRC) are biologically distinct from and more primitive than most cells that can be assayed in vitro. Here we demonstrate through limiting dilution analysis that the NOD/SCID xenotransplant model provides a quantitative assay for SRC. Using this assay, the frequency of SRC in cord blood (CB) was found to be 1 in 9.3 × 105 cells. This was significantly higher than the frequency of 1 SRC in 3.0 × 106 adult BM cells or 1 in 6.0 × 106 mobilized peripheral blood (PB) cells from normal donors. Mice transplanted with limiting numbers of SRC were engrafted with both lymphoid and multilineage myeloid human cells. This functional assay is currently the only available method for quantitative analysis of human hematopoietic cells with repopulating capacity. Both CB and mobilized PB are increasingly being used as alternative sources of hematopoietic stem cells in allogeneic transplantation. Thus, the findings reported here will have important clinical as well as biologic implications.     INTRODUCTION Abstract Introduction Methods Results Discussion References A QUANTITATIVE ASSAY for human stem cells is essential for the study of the biologic properties of these cells. Such an assay would also allow a more rational approach to the development of clinical treatments involving transplantation, ex vivo stem cell expansion, and gene therapy. To date, quantitative analysis of primitive hematopoietic cells has been limited to in vitro studies using colony assays or long-term cultures (LTC). However, colony assays detect only committed and multipotent progenitors (colony-forming cells, CFC). LTC assays detect more primitive cells (LTC-initiating cells, LTC-IC) capable of giving rise to CFC after at least 5 weeks of culture on competent feeder layers.1,2 However, LTC-IC are functionally heterogeneous: characteristics associated with very immature cells such as quiescence and the capacity to generate progenitors in extended culture are found in only a small subpopulation of LTC-IC.3 In addition, the relationship between LTC-IC and in vivo repopulating human stem cells is not clear. We have previously reported the development of an in vivo functional assay for primitive human hematopoietic cells based on their ability to repopulate the bone marrow (BM) of severe combined immunodeficient (SCID) and nonobese diabetic/SCID (NOD/SCID) mice after intravenous injection.4-6 Transplantation of human BM or umbilical cord blood (CB) results in the engraftment of primitive cells that proliferate and differentiate to multiple lineages in the murine BM.4,5 We have operationally defined the engrafting human cell as a SCID-repopulating cell (SRC). Kinetic experiments showed that only 0.1% of injected CFC and LTC-IC are detectable in the murine BM 2 days posttransplant, and that there is a large expansion of these cells as well as of primitive CD34+ and CD34+Thy-1+ cells over the next 4 weeks, implying their production from a more primitive cell.7 Recent experiments using retroviral gene transfer showed that while CFC and LTC-IC are easily transduced, these gene-marked cells do not contribute significantly to the repopulation of engrafted mice; a corollary to this finding is that the efficiency of gene transfer into SRC is low.8 Finally, cell purification experiments showed that SRC are exclusively CD34+CD38-,8,9 in contrast to CFC and LTC-IC, which are also found in the CD34+CD38+ fraction. Together, these data indicate that SRC are biologically distinct from and more primitive than most CFC and LTC-IC. In this report we show that the NOD/SCID xenotransplant model, or SRC assay, provides a quantitative in vivo assay for primitive human hematopoietic cells. We have used this assay to measure and compare the frequency of SRC in human CB, normal adult BM, and mobilized peripheral blood (PB) from normal donors. Our results show that CB is enriched for these primitive hematopoietic cells compared with BM or mobilized PB, an observation that has important implications for clinical transplantation and stem cell expansion strategies.     MATERIALS AND METHODS Abstract Introduction Methods Results Discussion References Donor samples. CB samples were obtained from umbilical and placental tissues scheduled for discard. BM and granulocyte colony-stimulating factor (G-CSF )-mobilized PB samples from normal adult donors were obtained as leftover cells from harvests for allogeneic transplantation according to procedures approved by the Human Experimentation Committee at the Princess Margaret Hospital, Toronto, Ontario, Canada. CB and BM samples were diluted 1:2 or 1:3 in Iscove's modified Dulbecco's medium (IMDM; GIBCO-BRL, Burlington, Ontario, Canada) containing 10% fetal calf serum (FCS; Cansera, Rexdale, Ontario, Canada) and enriched for mononuclear cells by centrifugation on Ficoll-Paque (Pharmacia, Baie d'Urfé, Quebec, Canada). Mobilized PB was collected by leukapheresis on days 4 and 5 from normal individuals treated with G-CSF 5 to 10 µg/kg subcutaneously on days 1 through 4. View larger version (61K): [in this window] [in a new window]   Fig 1. Limiting dilution assays of adult BM and umbilical CB. (A) Southern blot analysis of human cell engraftment in the BM of mice transplanted with 1 to 8 × 106 BM cells. Mice were treated with alternate-day injections of human cytokines and killed 6 weeks posttransplant. Human:mouse DNA controls are given as percent human DNA. (B and C) Southern blot analysis of mice transplanted with 1 × 105 to 8 × 106 CB cells and killed after 6 weeks. Transplantation of human cells into NOD/SCID mice. CB, BM, or mobilized PB cells were transplanted by tail-vein injection into sublethally irradiated (375 to 400 cGy using a 137Cs -irradiator) 8-week-old NOD/LtSz-scid/scid (NOD/SCID) mice according to our standard protocol.4-6 Mice transplanted with BM or PB received alternate-day intraperitoneal injections of human cytokines (huSCF 10 µg, huIL-3 and huGM-CSF 6 µg each; all from Amgen, Thousand Oaks, CA). NOD/SCID mice were bred and maintained in the defined flora animal colony at the Ontario Cancer Institute, Toronto, and the animal experiments were approved by the Animal Care Committee of the Hospital for Sick Children and the Ontario Cancer Institute. Mice were killed 4 to 6 weeks after transplantation, and the BM from 2 femurs, 2 tibiae, and 2 iliac crests was flushed into IMDM plus 10% FCS.   View this table: [in this window] [in a new window]   Table 1. Limiting Dilution Analysis of Human CB, Adult BM, and Mobilized PB Analysis of human cell engraftment. High-molecular-weight DNA was isolated from the BM of transplanted mice by phenol/chloroform extraction using standard protocols. The proportion of human cells in the murine BM was quantified by Southern blot analysis using a human chromosome 17-specific -satellite probe (p17H8)10 as previously described (limit of detection approximately 0.05% human cells).4,5 This technique is more reliable than flow cytometry in detecting very low levels of human cell engraftment. To determine whether human progenitors were present in the BM of engrafted mice, BM cells from transplanted mice were plated in methylcellulose cultures as previously described5,11 under conditions that are selective for the growth of human progenitors and that do not support coexisting mouse progenitors. Colonies were scored at 14 days. The presence of human lymphoid cells in the BM of some mice was assessed by flow cytometry on a FACScan analyzer (Becton Dickinson, San Jose, CA) using human-specific monoclonal antibodies directed against the pan-B-cell marker CD19 (B4; Coulter Immunology, Hialeah, FL) in combination with anti-CD45 (HLe-1) or anti-CD38 (Leu-17) antibodies (both from Becton Dickinson).5 More detailed lineage analysis by flow cytometry was carried out in some mice as described elsewhere.9 Statistical analysis. For purposes of our limiting dilution assays, a transplanted mouse was scored as positive (engrafted) if any human cells were detectable in the murine BM by Southern blot analysis. For each cell source, the data from several limiting dilution experiments were pooled and analyzed by applying Poisson statistics to the single-hit model.12 The major assumptions of this model are that transplantation of only 1 SRC is required to generate a positive response (an engrafted mouse), and that every transplanted SRC will generate a positive response.13 The frequency of SRC in each cell source was calculated using the maximum likelihood estimator.12,13 2 provides a measure of the legitimacy of using pooled data and of the validity of applying the single-hit model.12,13 View larger version (10K): [in this window] [in a new window]   Fig 2. Comparison of the frequency of SRC in CB, BM, and mobilized PB. The frequency of SRC was calculated using Poisson statistics. Bars indicate the 95% confidence limits.   View this table: [in this window] [in a new window]   Table 2. Multilineage Engraftment in the BM of Mice Transplanted With SRC in Limiting Doses     RESULTS Abstract Introduction Methods Results Discussion References Limiting dilution assays of CB, adult BM, and mobilized PB. Groups of sublethally irradiated mice were transplanted with replicate doses of mononuclear cells from CB or normal adult BM over a range of doses which resulted in nonengraftment in a fraction of the mice. Six weeks posttransplant, the murine BM was analyzed by Southern blot, and mice were scored as positive or negative for human cell engraftment. The Southern blot analysis of three representative experiments is shown in Fig 1. Transplantation of 1 × 106 to 8 × 106 BM cells resulted in low levels of engraftment, with positive and negative mice at each dose (Fig 1A). In contrast, transplantation of CB cells over the same dose range resulted in much higher levels of engraftment overall, and all of the mice transplanted with 4 × 106 or 8 × 106 cells were engrafted (Fig 1B). Transplantation of lower numbers of CB cells gave similar results as those seen with the higher doses of BM (Fig 1C). View larger version (40K): [in this window] [in a new window]   Fig 3. Multilineage engraftment in the BM of a mouse transplanted with CB cells at limiting dilution. BM from a mouse transplanted with 1 × 106 CB cells and killed after 6 weeks was stained with human-specific monoclonal antibodies and analyzed by flow cytometry. (A) Histogram of pan-leukocyte marker CD45 expression demonstrating 3% human cell engraftment in this mouse. (B) Cells for analysis were acquired in a live gate (R1) based on CD45 positivity and medium to high forward scatter. (C) Cells were further gated based on forward and side scatter properties into lymphoid/blast (R2) and myeloid (R3) windows. (D) Isotype control for nonspecific IgG staining of cells in R2. (E) Expression of CD38 and CD19, a pan-B-cell marker, on cells in R2. (F ) Isotype control for cells in R3. (G) Expression of myeloid marker CD33 and monocytic marker CD14 on cells in R3. (H) Expression of myeloid marker CD13 and mature granulocyte marker CD15 on cells in R3. To determine whether our model could also be used to assay primitive hematopoietic cells in G-CSF-mobilized PB from normal individuals, we transplanted mononuclear cells from leukapheresis products into NOD/SCID mice using our standard protocol. Flow cytometric analysis and progenitor assays of the BM of engrafted mice demonstrated B-lymphoid and multilineage myeloid engraftment similar to results we obtained with transplantation of human BM or CB (data not shown). Transplantation of mobilized PB in limiting dilution assays resulted in low levels of engraftment in a proportion of transplanted mice after 4 to 6 weeks, as was observed with BM and CB. The data from the limiting dilution assays of CB (n experiments = 7), adult BM (n = 5), and mobilized PB (n = 7) are shown in Table 1. Of the total number of mice in which human cells were detectable by Southern blot, 92% were engrafted at a level of 0.1% and 95% had human progenitors in the murine BM. Frequency of SRC in various hematopoietic tissues. Data from the limiting dilution assays of each cell source were pooled for statistical analysis, according to the method described by Porter and Berry.12 The frequency of SRC was calculated using the maximum likelihood estimator.12,13 The value of 2 in all cases was not statistically significant (P > .05), demonstrating internal consistency in our assays and allowing pooling of the data. The frequency of SRC in CB was 1 in 9.3 × 105 mononuclear cells (95% confidence limits [CL] 1 in 5.8 × 105 to 1 in 1.5 × 106). This was significantly higher than the calculated frequency of 1 SRC in 3.0 × 106 BM cells (95% CL 1 in 1.8 × 106 to 1 in 5.2 × 106) or 1 in 6.0 × 106 mobilized PB cells (95% CL 1 in 3.1 × 106 to 1 in 1.2 × 107) (Fig 2). As confirmation of the validity of applying the single-hit Poisson model to our assay, the frequency of SRC was also determined by minimum 2 estimation.13 Calculated frequencies using this second method were similar, and 2 was again not significant in all cases (P > .05, data not shown). To assess the differentiative capacity of SRC transplanted in limiting doses, we analyzed additional groups of mice injected with 1 × 106 mononuclear CB cells for evidence of both lymphoid and myeloid differentiation. At this dose, 12 of 30 mice had engraftment detectable by flow cytometry, and by Poisson statistics one half to three quarters of these likely received only 1 SRC. All of the engrafted mice had human CD19+ B-lymphoid cells as well as multiple lineages of human myeloid clonogenic progenitors in their BM (Table 2). Detailed flow cytometric analysis in a number of mice (n = 3) provided independent confirmation that multiple myeloid lineages as well as B cells were present in the BM of engrafted mice (Fig 3).     DISCUSSION Abstract Introduction Methods Results Discussion References We have shown through limiting dilution analysis that the NOD/SCID xenotransplant model provides an in vivo quantitative assay for primitive human hematopoietic cells. Using this assay we measured the frequency of SRC in various hematopoietic tissues, and showed that CB is enriched for these primitive repopulating cells compared with adult BM or mobilized PB. The higher frequency of SRC in CB compared with adult tissues suggests that CB may be a better source of stem cells for ex vivo manipulations such as retroviral infection or stem cell expansion. For this analysis we assumed a single-hit Poisson model for the generation of a positive response (an engrafted mouse). The underlying postulate of this statistical model is that only one cell of only one cell type is necessary for a positive response.13 The applicability of the single-hit model to our NOD/SCID assay, as validated by the 2 test, further supports the hypothesis that the human graft is initiated from a single cell type (the SRC) capable of multilineage differentiation, rather than from many lineage-restricted cells. Importantly, the ability to quantitate SRC allowed us to assess their differentiative capacity more directly by analyzing the human hematopoietic lineages present in the BM of mice transplanted with limiting numbers of SRC. The presence of both lymphoid cells and multiple lineages of myeloid progenitors in all of the engrafted mice, most of which likely received a single SRC, provides strong evidence that this assay detects a primitive cell in the human hematopoietic hierarchy. Previous studies have reported that the frequency of LTC-IC in normal human BM is approximately 1 in 1 × 104 to 1 in 3 × 104 cells, and that the proportion of LTC-IC in mobilized PB is similar to or higher than that in BM and CB.2,14 The higher frequency of LTC-IC compared with SRC reflects the fact that in vitro LTC assays detect a functionally heterogeneous cell population that includes more mature progenitors in addition to primitive cells. Mobilized PB is enriched for more mature hematopoietic precursors15; however, we have evidence that these cells do not read out in the SRC assay.8 Because the SRC assay quantitatively detects a very primitive hematopoietic cell, it can provide a more clinically relevant measure of the degree of stem cell enrichment achieved by various purification strategies.9 The NOD/SCID xenotransplant model will be an important tool in studies to define the proliferative, differentiative, and self-renewal capacities of primitive human hematopoietic cells. As well, this assay now provides a means to quantify changes in stem cell function in response to a variety of conditions in vivo and in vitro, and to assess how ex vivo manipulations such as retroviral infection protocols or expansion culture techniques affect the maintenance of stem cell activity as measured by repopulating capacity (Bhatia et al, submitted for publication). Both CB and mobilized PB from normal donors are increasingly being used as alternative sources of hematopoietic stem cells in allogeneic transplantation.16-18 Thus, the findings reported here will have important clinical as well as biologic implications.     FOOTNOTES    Submitted November 6, 1996; accepted March 4, 1997.    Supported by grants from the Medical Research Council (MRC) of Canada, the National Cancer Institute of Canada (NCIC) with funds from the Canadian Cancer Society, and AMGEN, with postdoctoral fellowships from the Leukemia Research Fund of Canada and the MRC (J.C.Y.W.), a Research Scientist award from the NCIC (J.E.D.), and an MRC Scientist Award (J.E.D.)    Address reprint requests to John E. Dick, PhD, Department of Genetics, Research Institute, Hospital for Sick Children, 555 University Ave, Toronto, Ontario, Canada M5G 1X8.    The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hearly marked ``advertisment'' in accordance with 18 U.S.C. section 1734 solely to indicate this fact.     ACKNOWLEDGMENT The authors thank N. Jamal and H. Messner for providing bone marrow and mobilized peripheral blood samples, L. McWhirter and S. Lye for providing cord blood specimens, I. McNiece (Amgen, Thousand Oaks, CA) for providing cytokines, and members of the lab for critically reviewing the manuscript.     REFERENCES Abstract Introduction Methods Results Discussion References 1. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM: Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74:1563, 1989[Abstract/Free Full Text] 2. Sutherland HJ, Lansdorp PM, Henkelman DH, Eaves AC, Eaves CJ: Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 87:3584, 1990[Abstract/Free Full Text] 3. Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM: A functional comparison of CD34+CD38- cells in cord blood and bone marrow. Blood 86:3745, 1995[Abstract/Free Full Text] 4. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick J: Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137, 1992[Abstract/Free Full Text] 5. Vormoor Lapidot T, Pflumio F, Risdon G, Patterson B, Broxmeyer HE, Dick JE: Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 83:2489, 1994[Abstract/Free Full Text] 6. Larochelle A, Vormoor J, Lapidot T, Sher G, Furukawa T, Li Q, Shultz LD, Olivieri NF, Stamatoyannopoulos G, Dick JE: Engraftment of immune-deficient mice with primitive hematopoietic cells from -thalassemia and sickle cell anemia patients: Implications for evaluating human gene therapy protocols. Hum Mol Genet 4:163, 1995[Abstract/Free Full Text] 7. Cashman JD, Lapidot T, Wang JCY, Doedens M, Shultz LD, Lansdorp P, Dick JE, Eaves CJ: Kinetic evidence of the regeneration of multi-lineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood (in press) 8. Larochelle A, Vormoor J, Hanenberg H, Wang JCY, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato I, Williams DA, Dick JE: Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nature Med 2:1329, 1996[Medline] [Order article via Infotrieve] 9. Bhatia M, Wang JCY, Kapp U, Bonnet D, Dick JE: Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA (in press) 10. Waye S, Willard H: Structure, organization and sequence of alpha satellite DNA from human chromosome 17: Evidence for evolution by unequal crossing-over and an ancestral pentamer repeat shared with the human X chromosome. Mol Cell Biol 6:3156, 1986[Abstract/Free Full Text] 11. Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B, Jamal N, Messner H, Addy L, Minden M, Laraya P, Keating A, Eaves A, Lansdorp PM, Eaves CJ, Dick JE: Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87:1539, 1996[Abstract/Free Full Text] 12. Porter EH, Berry RJ: The efficient design of transplantable tumour assays. Br J Cancer 17:583, 1964 13. Taswell C: Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 126:1614, 1981[Abstract] 14. Pettengell R, Luft T, Henschler R, Hows JM, Dexter TM, Ryder D, Testa NG: Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells. Blood 84:3653, 1994[Abstract/Free Full Text] 15. Tjonnfjord GE, Steen R, Evensen SA, Thorsby E, Egeland T: Characterization of CD34+ peripheral blood cells from healthy young adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 84:2795, 1994[Abstract/Free Full Text] 16. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995[Abstract/Free Full Text] 17. Korbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 85:1659, 1995[Abstract/Free Full Text] 18. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, Ciocci G, Carrier C, Stevens CE, Rubinstein P: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335:157, 1996[Abstract/Free Full Text] © 1997 by The American Society of Hematology. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: H. Haeno, R. L. Levine, D. G. Gilliland, and F. Michor A progenitor cell origin of myeloid malignancies PNAS, September 29, 2009; 106(39): 16616 - 16621. [Abstract] [Full Text] [PDF] R. Safi, G. G. Muramoto, A. B. Salter, S. Meadows, H. Himburg, L. Russell, P. Daher, P. Doan, M. D. Leibowitz, N. J. Chao, et al. Pharmacological Manipulation of the RAR/RXR Signaling Pathway Maintains the Repopulating Capacity of Hematopoietic Stem Cells in Culture Mol. Endocrinol., February 1, 2009; 23(2): 188 - 201. [Abstract] [Full Text] [PDF] J. E. Dick Stem cell concepts renew cancer research Blood, December 15, 2008; 112(13): 4793 - 4807. [Abstract] [Full Text] [PDF] M. Narisawa-Saito, Y. Yoshimatsu, S.-i. Ohno, T. Yugawa, N. Egawa, M. Fujita, S. Hirohashi, and T. Kiyono An In vitro Multistep Carcinogenesis Model for Human Cervical Cancer Cancer Res., July 15, 2008; 68(14): 5699 - 5705. [Abstract] [Full Text] [PDF] O. Christ, K. Lucke, S. Imren, K. Leung, M. Hamilton, A. Eaves, C. Smith, and C. Eaves Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity Haematologica, September 1, 2007; 92(9): 1165 - 1172. [Abstract] [Full Text] [PDF] T. Yahata, S. Yumino, Y. Seng, H. Miyatake, T. Uno, Y. Muguruma, M. Ito, H. Miyoshi, S. Kato, T. Hotta, et al. Clonal analysis of thymus-repopulating cells presents direct evidence for self-renewal division of human hematopoietic stem cells Blood, October 1, 2006; 108(7): 2446 - 2454. [Abstract] [Full Text] [PDF] J. P. Chute, G. G. Muramoto, J. Whitesides, M. Colvin, R. Safi, N. J. Chao, and D. P. McDonnell Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells PNAS, August 1, 2006; 103(31): 11707 - 11712. [Abstract] [Full Text] [PDF] K. Nonome, X.-K. Li, T. Takahara, Y. Kitazawa, N. Funeshima, Y. Yata, F. Xue, M. Kanayama, E. Shinno, C. Kuwae, et al. Human umbilical cord blood-derived cells differentiate into hepatocyte-like cells in the Fas-mediated liver injury model Am J Physiol Gastrointest Liver Physiol, December 1, 2005; 289(6): G1091 - G1099. [Abstract] [Full Text] [PDF] L. D. Shultz, B. L. Lyons, L. M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S. D. Gillies, M. King, J. Mangada, et al. Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2R{gamma}null Mice Engrafted with Mobilized Human Hemopoietic Stem Cells J. Immunol., May 15, 2005; 174(10): 6477 - 6489. [Abstract] [Full Text] [PDF] J. P. Chute, G. G. Muramoto, J. Fung, and C. Oxford Soluble factors elaborated by human brain endothelial cells induce the concomitant expansion of purified human BM CD34+CD38- cells and SCID-repopulating cells Blood, January 15, 2005; 105(2): 576 - 583. [Abstract] [Full Text] [PDF] M. Wysoczynski, R. Reca, J. Ratajczak, M. Kucia, N. Shirvaikar, M. Honczarenko, M. Mills, J. Wanzeck, A. Janowska-Wieczorek, and M. Z. Ratajczak Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient Blood, January 1, 2005; 105(1): 40 - 48. [Abstract] [Full Text] [PDF] L. Xia, J. M. McDaniel, T. Yago, A. Doeden, and R. P. McEver Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow Blood, November 15, 2004; 104(10): 3091 - 3096. [Abstract] [Full Text] [PDF] A. Kiani, I. Habermann, M. Haase, S. Feldmann, S. Boxberger, M. A. Sanchez-Fernandez, C. Thiede, M. Bornhauser, and G. Ehninger Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation J. Leukoc. Biol., November 1, 2004; 76(5): 1057 - 1065. [Abstract] [Full Text] [PDF] D. A. Hess, T. E. Meyerrose, L. Wirthlin, T. P. Craft, P. E. Herrbrich, M. H. Creer, and J. A. Nolta Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity Blood, September 15, 2004; 104(6): 1648 - 1655. [Abstract] [Full Text] [PDF] M. Kobune, Y. Ito, Y. Kawano, K. Sasaki, H. Uchida, K. Nakamura, H. Dehari, H. Chiba, R. Takimoto, T. Matsunaga, et al. Indian hedgehog gene transfer augments hematopoietic support of human stromal cells including NOD/SCID-{beta}2m-/- repopulating cells. Blood, August 15, 2004; 104(4): 1002 - 1009. [Abstract] [Full Text] [PDF] N. Uchida, B. Dykstra, K. Lyons, F. Leung, M. Kristiansen, and C. Eaves ABC transporter activities of murine hematopoietic stem cells vary according to their developmental and activation status Blood, June 15, 2004; 103(12): 4487 - 4495. [Abstract] [Full Text] [PDF] M. Asheuer, F. Pflumio, S. Benhamida, A. Dubart-Kupperschmitt, F. Fouquet, Y. Imai, P. Aubourg, and N. Cartier Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein PNAS, March 9, 2004; 101(10): 3557 - 3562. [Abstract] [Full Text] [PDF] D.-W. Kim, Y.-J. Chung, T.-G. Kim, Y.-L. Kim, and I.-H. Oh Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation Blood, March 1, 2004; 103(5): 1941 - 1948. [Abstract] [Full Text] [PDF] Y. Y. Ng, B. van Kessel, H. M. Lokhorst, M. R. M. Baert, C. M. M. van den Burg, A. C. Bloem, and F. J. T. Staal Gene-expression profiling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity J. Leukoc. Biol., February 1, 2004; 75(2): 314 - 323. [Abstract] [Full Text] [PDF] P. Rollini, S. Kaiser, E. Faes-van't Hull, U. Kapp, and S. Leyvraz Long-term expansion of transplantable human fetal liver hematopoietic stem cells Blood, February 1, 2004; 103(3): 1166 - 1170. [Abstract] [Full Text] [PDF] S. Brenner, N. L. Whiting-Theobald, G. F. Linton, K. L. Holmes, M. Anderson-Cohen, P. F. Kelly, E. F. Vanin, A. M. Pilon, D. M. Bodine, M. E. Horwitz, et al. Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/{beta}2-microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells Blood, October 15, 2003; 102(8): 2789 - 2797. [Abstract] [Full Text] [PDF] F. Frassoni, M. Podesta, R. Maccario, G. Giorgiani, G. Rossi, M. Zecca, A. Bacigalupo, G. Piaggio, and F. Locatelli Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation Blood, August 1, 2003; 102(3): 1138 - 1141. [Abstract] [Full Text] [PDF] C. P. Kalberer, U. Siegler, and A. Wodnar-Filipowicz Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells Blood, July 1, 2003; 102(1): 127 - 135. [Abstract] [Full Text] [PDF] T. Yahata, K. Ando, T. Sato, H. Miyatake, Y. Nakamura, Y. Muguruma, S. Kato, and T. Hotta A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow Blood, April 15, 2003; 101(8): 2905 - 2913. [Abstract] [Full Text] [PDF] S. Kuci, J. T. Wessels, H.-J. Buhring, K. Schilbach, M. Schumm, G. Seitz, J. Loffler, P. Bader, P. G. Schlegel, D. Niethammer, et al. Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells Blood, February 1, 2003; 101(3): 869 - 876. [Abstract] [Full Text] [PDF] Y. Kawano, M. Kobune, M. Yamaguchi, K. Nakamura, Y. Ito, K. Sasaki, S. Takahashi, T. Nakamura, H. Chiba, T. Sato, et al. Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells Blood, January 15, 2003; 101(2): 532 - 540. [Abstract] [Full Text] [PDF] M. I. D. Rossi, T. Yokota, K. L. Medina, K. P. Garrett, P. C. Comp, A. H. Schipul Jr, and P. W. Kincade B lymphopoiesis is active throughout human life, but there are developmental age-related changes Blood, January 15, 2003; 101(2): 576 - 584. [Abstract] [Full Text] [PDF] M. Y. Gordon, J. L. Lewis, and S. B. Marley Of mice and men ... and elephants Blood, December 15, 2002; 100(13): 4679 - 4679. [Full Text] [PDF] J. Roesler, S. Brenner, A. A. Bukovsky, N. Whiting-Theobald, T. Dull, M. Kelly, C. I. Civin, and H. L. Malech Third-generation, self-inactivating gp91phox lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease Blood, December 15, 2002; 100(13): 4381 - 4390. [Abstract] [Full Text] [PDF] J. P. Chute, A. A. Saini, D. J. Chute, M. R. Wells, W. B. Clark, D. M. Harlan, J. Park, M. K. Stull, C. Civin, and T. A. Davis Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow Blood, December 15, 2002; 100(13): 4433 - 4439. [Abstract] [Full Text] [PDF] J. L. Abkowitz, S. N. Catlin, M. T. McCallie, and P. Guttorp Evidence that the number of hematopoietic stem cells per animal is conserved in mammals Blood, September 18, 2002; 100(7): 2665 - 2667. [Abstract] [Full Text] [PDF] D. A. Hess, K. D. Levac, F. N. Karanu, M. Rosu-Myles, M. J. White, L. Gallacher, B. Murdoch, M. Keeney, P. Ottowski, R. Foley, et al. Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor Blood, July 18, 2002; 100(3): 869 - 878. [Abstract] [Full Text] [PDF] E. J. Tsai, H. L. Malech, M. R. Kirby, A. P. Hsu, N. E. Seidel, C. D. Porada, E. D. Zanjani, D. M. Bodine, and J. M. Puck Retroviral transduction of IL2RG into CD34+ cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras Blood, June 17, 2002; 100(1): 72 - 79. [Abstract] [Full Text] [PDF] N. C. Josephson, G. Vassilopoulos, G. D. Trobridge, G. V. Priestley, B. L. Wood, T. Papayannopoulou, and D. W. Russell Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors PNAS, June 11, 2002; 99(12): 8295 - 8300. [Abstract] [Full Text] [PDF] J. L. Abkowitz Can Human Hematopoietic Stem Cells Become Skin, Gut, or Liver Cells? N. Engl. J. Med., March 7, 2002; 346(10): 770 - 772. [Full Text] [PDF] M. Scherr, K. Battmer, U. Blomer, B. Schiedlmeier, A. Ganser, M. Grez, and M. Eder Lentiviral gene transfer into peripheral blood-derived CD34+ NOD/SCID-repopulating cells Blood, January 15, 2002; 99(2): 709 - 712. [Abstract] [Full Text] [PDF] T. C. C. Kerre, G. De Smet, M. De Smedt, F. Offner, J. De Bosscher, J. Plum, and B. Vandekerckhove Both CD34+38+ and CD34+38- Cells Home Specifically to the Bone Marrow of NOD/LtSZ scid/scid Mice but Show Different Kinetics in Expansion J. Immunol., October 1, 2001; 167(7): 3692 - 3698. [Abstract] [Full Text] [PDF] S J Proctor, A M Dickinson, T Parekh, and C Chapman Umbilical cord blood banks in the UK BMJ, July 14, 2001; 323(7304): 60 - 61. [Full Text] [PDF] J M Hows Status of umbilical cord blood transplantation in the year 2001 J. Clin. Pathol., June 1, 2001; 54(6): 428 - 434. [Abstract] [Full Text] [PDF] L. E. Perez, H. M. Rinder, C. Wang, J. B. Tracey, N. Maun, and D. S. Krause Xenotransplantation of immunodeficient mice with mobilized human blood CD34+ cells provides an in vivo model for human megakaryocytopoiesis and platelet production Blood, March 15, 2001; 97(6): 1635 - 1643. [Abstract] [Full Text] [PDF] M. A. Vickers, E. McLeod, T. D. Spector, and I. J. Wilson Assessment of mechanism of acquired skewed X inactivation by analysis of twins Blood, March 1, 2001; 97(5): 1274 - 1281. [Abstract] [Full Text] [PDF] F. R. Appelbaum, J. M. Rowe, J. Radich, and J. E. Dick Acute Myeloid Leukemia Hematology, January 1, 2001; 2001(1): 62 - 86. [Abstract] [Full Text] [PDF] M. Rosu-Myles, L. Gallacher, B. Murdoch, D. A. Hess, M. Keeney, D. Kelvin, L. Dale, S. S. G. Ferguson, D. Wu, F. Fellows, et al. The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression PNAS, December 19, 2000; 97(26): 14626 - 14631. [Abstract] [Full Text] [PDF] N.-B. Woods, C. Fahlman, H. Mikkola, I. Hamaguchi, K. Olsson, R. Zufferey, S. E. Jacobsen, D. Trono, and S. Karlsson Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells Blood, December 1, 2000; 96(12): 3725 - 3733. [Abstract] [Full Text] [PDF] S.-R. Goan, I. Junghahn, M. Wissler, M. Becker, J. Aumann, U. Just, G. Martiny-Baron, I. Fichtner, and R. Henschler Donor stromal cells from human blood engraft in NOD/SCID mice Blood, December 1, 2000; 96(12): 3971 - 3978. [Abstract] [Full Text] [PDF] J. D. Cashman and C. J. Eaves High marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice Blood, December 1, 2000; 96(12): 3979 - 3981. [Abstract] [Full Text] [PDF] J. L. Abkowitz, D. Golinelli, D. E. Harrison, and P. Guttorp In vivo kinetics of murine hemopoietic stem cells Blood, November 15, 2000; 96(10): 3399 - 3405. [Abstract] [Full Text] [PDF] B. Hennemann, I.-H. Oh, J. Y. Chuo, C. P. Kalberer, P. D. Schley, S. Rose-John, R. K. Humphries, and C. J. Eaves Efficient retrovirus-mediated gene transfer to transplantable human bone marrow cells in the absence of fibronectin Blood, October 1, 2000; 96(7): 2432 - 2439. [Abstract] [Full Text] [PDF] J. Wilpshaar, J. H. F. Falkenburg, X. Tong, W. A. Noort, R. Breese, D. Heilman, H. Kanhai, C. M. Orschell-Traycoff, and E. F. Srour Similar repopulating capacity of mitotically active and resting umbilical cord blood CD34+ cells in NOD/SCID mice Blood, September 15, 2000; 96(6): 2100 - 2107. [Abstract] [Full Text] [PDF] L. Gallacher, B. Murdoch, D. Wu, F. Karanu, F. Fellows, and M. Bhatia Identification of novel circulating human embryonic blood stem cells Blood, September 1, 2000; 96(5): 1740 - 1747. [Abstract] [Full Text] [PDF] P. Kurre, S. Burdach;, C.-C. Shih, and S. J. Forman A potential role for leukemia inhibitory factor in the increased clonogenicity of human fetal progenitor cells Blood, August 1, 2000; 96(3): 1199 - 1200. [Full Text] [PDF] O. Kollet, A. Peled, T. Byk, H. Ben-Hur, D. Greiner, L. Shultz, and T. Lapidot beta 2 Microglobulin-deficient (B2mnull) NOD/SCID mice are excellent recipients for studying human stem cell function Blood, May 15, 2000; 95(10): 3102 - 3105. [Abstract] [Full Text] [PDF] C. Campagnoli, N. Fisk, T. Overton, P. Bennett, T. Watts, and I. Roberts Circulating hematopoietic progenitor cells in first trimester fetal blood Blood, March 15, 2000; 95(6): 1967 - 1972. [Abstract] [Full Text] [PDF] B. Schiedlmeier, K. Kuhlcke, H. G. Eckert, C. Baum, W. J. Zeller, and S. Fruehauf Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice Blood, February 15, 2000; 95(4): 1237 - 1248. [Abstract] [Full Text] [PDF] C. Cobaleda, N. Gutierrez-Cianca, J. Perez-Losada, T. Flores, R. Garcia-Sanz, M. Gonzalez, and I. Sanchez-Garcia A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia Blood, February 1, 2000; 95(3): 1007 - 1013. [Abstract] [Full Text] [PDF] P. B. van Hennik, A. E. de Koning, and R. E. Ploemacher Seeding Efficiency of Primitive Human Hematopoietic Cells in Nonobese Diabetic/Severe Combined Immune Deficiency Mice: Implications for Stem Cell Frequency Assessment Blood, November 1, 1999; 94(9): 3055 - 3061. [Abstract] [Full Text] [PDF] B. L. Ziegler, M. Valtieri, G. A. Porada, R. D. Maria, R. Müller, B. Masella, M. Gabbianelli, I. Casella, E. Pelosi, T. Bock, et al. KDR Receptor: A Key Marker Defining Hematopoietic Stem Cells Science, September 3, 1999; 285(5433): 1553 - 1558. [Abstract] [Full Text] L. E. Ailles, B. Gerhard, H. Kawagoe, and D. E. Hogge Growth Characteristics of Acute Myelogenous Leukemia Progenitors That Initiate Malignant Hematopoiesis in Nonobese Diabetic/Severe Combined Immunodeficient Mice Blood, September 1, 1999; 94(5): 1761 - 1772. [Abstract] [Full Text] [PDF] C. Robin, F. Pflumio, W. Vainchenker, and L. Coulombel Identification of Lymphomyeloid Primitive Progenitor Cells in Fresh Human Cord Blood and in the Marrow of Nonobese Diabetic-Severe Combined Immunodeficient (NOD-SCID) Mice Transplanted with Human CD34+ Cord Blood Cells J. Exp. Med., May 17, 1999; 189(10): 1601 - 1610. [Abstract] [Full Text] [PDF] D. Dunon, N. Allioli, O. Vainio, C. Ody, and B.A. Imhof Quantification of T-Cell Progenitors During Ontogeny: Thymus Colonization Depends on Blood Delivery of Progenitors Blood, April 1, 1999; 93(7): 2234 - 2243. [Abstract] [Full Text] [PDF] J. D. Cashman and C. J. Eaves Human Growth Factor-Enhanced Regeneration of Transplantable Human Hematopoietic Stem Cells in Nonobese Diabetic/Severe Combined Immunodeficient Mice Blood, January 15, 1999; 93(2): 481 - 487. [Abstract] [Full Text] [PDF] J. C.M. van der Loo, H. Hanenberg, R. J. Cooper, F.-Y. Luo, E. N. Lazaridis, and D. A. Williams Nonobese Diabetic/Severe Combined Immunodeficiency (NOD/SCID) Mouse as a Model System to Study the Engraftment and Mobilization of Human Peripheral Blood Stem Cells Blood, October 1, 1998; 92(7): 2556 - 2570. [Abstract] [Full Text] [PDF] J.F. Tisdale, Y. Hanazono, S.E. Sellers, B.A. Agricola, M.E. Metzger, R.E. Donahue, and C.E. Dunbar Ex Vivo Expansion of Genetically Marked Rhesus Peripheral Blood Progenitor Cells Results in Diminished Long-Term Repopulating Ability Blood, August 15, 1998; 92(4): 1131 - 1141. [Abstract] [Full Text] [PDF] F. Dazzi, D. Capelli, R. Hasserjian, F. Cotter, M. Corbo, A. Poletti, W. Chinswangwatanakul, J. M. Goldman, and M. Y. Gordon The Kinetics and Extent of Engraftment of Chronic Myelogenous Leukemia Cells in Non-Obese Diabetic/Severe Combined Immunodeficiency Mice Reflect the Phase of the Donor's Disease: An In Vivo Model of Chronic Myelogenous Leukemia Biology Blood, August 15, 1998; 92(4): 1390 - 1396. [Abstract] [Full Text] [PDF] D. Orlic, L. J. Girard, S. M. Anderson, L. C. Pyle, M. C. Yoder, H. E. Broxmeyer, and D. M. Bodine Identification of Human and Mouse Hematopoietic Stem Cell Populations Expressing High Levels of mRNA Encoding Retrovirus Receptors Blood, May 1, 1998; 91(9): 3247 - 3254. [Abstract] [Full Text] [PDF] J. L. Abkowitz, M. Taboada, G. H. Shelton, S. N. Catlin, P. Guttorp, and J. V. Kiklevich An X chromosome gene regulates hematopoietic stem cell kinetics PNAS, March 31, 1998; 95(7): 3862 - 3866. [Abstract] [Full Text] [PDF] M. M.A. Verstegen, P. B. van Hennik, W. Terpstra, C. van den Bos, J. J. Wielenga, N. van Rooijen, R. E. Ploemacher, G. Wagemaker, and A. W. Wognum Transplantation of Human Umbilical Cord Blood Cells in Macrophage-Depleted SCID Mice: Evidence for Accessory Cell Involvement in Expansion of Immature CD34+CD38- Cells Blood, March 15, 1998; 91(6): 1966 - 1976. [Abstract] [Full Text] [PDF] M. A. Dao, A. J. Shah, G. M. Crooks, and J. A. Nolta Engraftment and Retroviral Marking of CD34+ and CD34+CD38- Human Hematopoietic Progenitors Assessed in Immune-Deficient Mice Blood, February 15, 1998; 91(4): 1243 - 1255. [Abstract] [Full Text] [PDF] M. Bhatia, D. Bonnet, U. Kapp, J. C.Y. Wang, B. Murdoch, and J. E. Dick Quantitative Analysis Reveals Expansion of Human Hematopoietic Repopulating Cells After Short-term Ex Vivo Culture J. Exp. Med., August 18, 1997; 186(4): 619 - 624. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Wang, J. C.Y. Articles by Dick, J. E. Search for Related Content PubMed PubMed Citation Articles by Wang, J. C.Y. Articles by Dick, J. E. Social Bookmarking                   What's this?

	Copyright © 1997 by American Society of Hematology         Online ISSN: 1528-0020